Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022

BUY
$5.86 - $13.23 $103,534 - $233,747
17,668 New
17,668 $128,000
Q1 2022

May 12, 2022

SELL
$10.92 - $16.41 $876,209 - $1.32 Million
-80,239 Closed
0 $0
Q4 2021

Feb 09, 2022

BUY
$15.81 - $18.99 $1.27 Million - $1.52 Million
80,239 New
80,239 $1.28 Million
Q3 2021

Nov 10, 2021

SELL
$12.68 - $17.79 $973,824 - $1.37 Million
-76,800 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$12.95 - $15.41 $430,717 - $512,536
33,260 Added 76.39%
76,800 $1.06 Million
Q1 2021

May 13, 2021

SELL
$14.42 - $21.39 $69,446 - $103,014
-4,816 Reduced 9.96%
43,540 $636,000
Q4 2020

Feb 12, 2021

SELL
$16.56 - $18.94 $169,210 - $193,528
-10,218 Reduced 17.44%
48,356 $840,000
Q3 2020

Nov 12, 2020

BUY
$17.41 - $19.89 $633,932 - $724,234
36,412 Added 164.3%
58,574 $1.07 Million
Q2 2020

Aug 12, 2020

SELL
$14.43 - $19.16 $139,379 - $185,066
-9,659 Reduced 30.35%
22,162 $396,000
Q1 2020

May 13, 2020

BUY
$11.67 - $22.53 $191,072 - $368,883
16,373 Added 105.99%
31,821 $516,000
Q4 2019

Feb 12, 2020

BUY
$16.33 - $21.37 $252,265 - $330,123
15,448 New
15,448 $278,000

Others Institutions Holding CHRS

About Coherus BioSciences, Inc.


  • Ticker CHRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,724,600
  • Market Cap $116M
  • Description
  • Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...
More about CHRS
Track This Portfolio

Track Alpha Crest Capital Management LLC Portfolio

Follow Alpha Crest Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Crest Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Crest Capital Management LLC with notifications on news.